Oxford Nanopore has appointed Peter Allen to non-executive director of the board. He currently serves as non-executive chairman on the boards of ProStrakan Group, Chroma Therapeutics, and Proximagen Neuroscience. Previously, he served as chief financial officer for Abacus Group and Celltech Group. He was also the deputy CEO of Celltech until the company was sold in 2004. Allen succeeds Riccardo Pigliucci, who is retiring.
Complete Genomics has appointed Keith Raffel to senior vice president and chief commercial officer. Previously, Raffel served as group vice president for Oracle and Siebel. He also founded UpShot, a cloud-computing start-up company, and served as its chairman and as a director. He holds a BA from Harvard College, a MA from the University of Oxford, and a JD from Harvard Law School.
Additionally, Mark Sutherland, formerly senior vice president of business development, is now vice president of business development at Complete Genomics.
Steven Salzberg, currently a professor of computer science and director of the Center for Bioinformatics and Computational Biology at the University of Maryland, will be leaving his post at the end of this week to become a professor of medicine and biostatistics at the McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins University School of Medicine.
Prior to joining UMD in 2005, Salzberg was senior director of bioinformatics at the Institute for Genomic Research. Prior to that he was an assistant and associate professor at Hopkins.
Salzberg holds a PhD in computer science from Harvard University and BA, MS, and MPhil degrees in English and computer science from Yale University.
Mihai Pop, currently an assistant professor in the UMD department of computer science, has been appointed acting director of the CBCB.